Senzime AB (FRA:6YC) Margin of Safety % (DCF FCF Based): N/A (As of Jul. 05, 2026)


FRA:6YC Senzime AB FRA:6YC
57 GF Score
Price €0.34
GF Value €0.85
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Senzime AB Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Senzime AB's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

FRA:6YC vs ABT, SYK, MDT: Margin of Safety % (DCF FCF Based) Comparison

For the Medical Devices subindustry, Senzime AB's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Senzime AB Margin of Safety % (DCF FCF Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Senzime AB's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Senzime AB's Margin of Safety % (DCF FCF Based) falls into.


FRA:6YC
57GF Score
Senzime AB FRA:6YC
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Senzime AB (FRA:6YC) Overvalued in 2026?

Based on GuruFocus' analysis, Senzime AB stock appears to be undervalued. The current stock price of €0.34 is trading 59.8% below its estimated GF Value™ of €0.85. GuruFocus considers Senzime AB to be Possible Value Trap.

Key valuation signals for FRA:6YC:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: €0.85 vs. price of €0.34 (59.8% below fair value)
  • GF Score™: 57/100 with 2 warning signs

No single metric tells the full story. See the FRA:6YC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Senzime AB Business Description

Other Exchanges SNZZF:USASEZI:Sweden
Address Verkstadsgatan 8, hus 1, Uppsala, SWE, 753 23
Senzime AB is a medical device company developing precision-based patient monitoring solutions for patients undergoing anesthesia. The company develops and markets precision-based monitoring systems for monitoring neuromuscular function and respiration during and after surgery, as well as for intensive care. Its product portfolio includes Next-generation TetraGraph, TetraGraph connectivity, TetraGraph for pediatric, Classic TetraGraph, and ExSpiron. The TetraGraph system is used in thousands of operating rooms internationally in university hospitals, public, private, military, and veterans hospitals. Senzime has direct sales resources in the USA and Germany and collaborates with distributors and licensees in its other main markets.
57GF Score

Get the complete analysis for FRA:6YC

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.34
Price
€0.85
GF Value